Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
22 March 2022 | Story André Damons
Dr Yolandi Swart
Dr Yolandi Swart, who took over from Prof Lynette van der Merwe as the new Director of the Undergraduate Medical Programme (MB ChB programme) in the School of Clinical Medicine within the Faculty of Health Sciences at the University of the Free State (UFS), says she is excited about the new opportunities that come with this position.

The new Director of the Undergraduate Medical Programme (MB ChB programme) in the School of Clinical Medicine within the Faculty of Health Sciences at the University of the Free State (UFS) has a passion for teaching and learning and brings a wealth of experience with her.

Dr Yolandi Swart, who took over from Prof Lynette van der Merwe on 1 March 2022, says she is excited about the new opportunities that this position brings. She was not actively job-hunting and came across the advertisement by accident but was thrilled when she was informed that she is the recommended candidate.

A deep love for the UFS

“I will be heading up an amazing team of people who drive the MB ChB programme, making sure that we walk with our students on their journey to become the next generation of health professionals who will contribute to the health and wellness of our population. Our functions include coordinating the undergraduate curriculum, providing student support, as well as logistic support to ensure the smooth running of the MB ChB programme,” says Dr Swart.

As an alumna of the university (she obtained both her MB ChB and postgraduate MMed in Community Health at the UFS), she has a deep love for the UFS, as it has played a huge role in developing her into the person she is today.

According to Dr Swart, she looks forward to getting to know the students and seeing them develop into the best they can be, as well as engaging with the academic staff as they guide and train the students. She brings a diverse background to the position, having practised as a doctor, specialised in Community Health, and worked in clinical research at various levels, including senior management. This has afforded her the opportunity to equip herself with skills that she hopes will provide support and direction to the Undergraduate Programme Management team in order to provide excellent service in all its functions.

Her vision

“I love teaching and learning – taking a concept and making it accessible to someone.  There are few things as satisfying as seeing that expression that says ‘Oh, now I get it!’

Kovsies has always had a reputation of producing excellent doctors.  “It is my vision to build on that reputation, integrating local and international best practices as they develop into our students’ training, with the aim of developing young professionals who are competent, resilient, and able to face the challenges that life will throw at them – so that they, in turn, can play their role to influence lives for the better.”

Prior to her appointment, she worked at FARMOVS as a clinical research physician for more than six years, the past year and a half as the company’s Medical Director. Says Dr Swart: “I love challenging myself with new things every so often. Past and present hobbies include surfing (which died an early death, as I was horrible at it), scuba diving (yes, with sharks as well), horse-riding, and self-defence.  Most recently, I got hooked on traditional archery – a very challenging skill to try and master.”

Dr Swart says she has learned throughout her personal life and professional career that life sometimes takes unexpected turns – but if one is open to the opportunities afforded by those unexpected turns, it often turns out so much better than the original plan could ever have been. “Difficulties and challenges will always come – but if one faces them with a positive attitude, they teach life skills that you would otherwise never have attained.”

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept